Dexcom (DXCM) EBIT Growth (3y) (2013 - 2026)
Dexcom (DXCM) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 13.06% |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | -0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.44% |
| Mar 31, 2026 | 75.54% |
| Dec 31, 2025 | 37.08% |
| Sep 30, 2025 | 18.02% |
| Jun 30, 2025 | 40.29% |
| Mar 31, 2025 | 47.93% |
| Dec 31, 2024 | 580.29% |
| Sep 30, 2024 | 8.71% |
| Jun 30, 2024 | 16.09% |
| Mar 31, 2024 | 30.11% |
| Dec 31, 2023 | 27.76% |
| Sep 30, 2023 | 29.74% |
| Jun 30, 2023 | 23.63% |
| Mar 31, 2023 | 12.00% |
| Dec 31, 2022 | 7.30% |
| Sep 30, 2022 | 38.10% |
| Jun 30, 2022 | 361.44% |
| Mar 31, 2022 | 69.48% |
| Dec 31, 2021 | 26.07% |
| Sep 30, 2021 | 104.17% |